Cargando…

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation

AIMS: Randomized trials showed non-inferior or superior results of the non-vitamin-K-antagonist oral anticoagulants (NOACs) compared with warfarin. The aim of this study was to assess the effectiveness and safety of dabigatran (direct thrombin inhibitor) vs. acenocoumarol (vitamin K antagonist) in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Korenstra, Jennie, Wijtvliet, E. Petra J., Veeger, Nic J.G.M., Geluk, Christiane A., Bartels, G. Louis, Posma, Jan L., Piersma-Wichers, Margriet, Van Gelder, Isabelle C., Rienstra, Michiel, Tieleman, Robert G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006960/ https://www.ncbi.nlm.nih.gov/pubmed/26843571 http://dx.doi.org/10.1093/europace/euv397

Ejemplares similares

Effect of switching from acenocoumarol to phenprocoumon on time in therapeutic range and INR variability: A cohort study
por: van Miert, Jasper H. A., et al.
Publicado: (2020)

Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study
por: Nguyen, Bao Oanh, et al.
Publicado: (2020)

Direct treatment comparison of DAbigatran and RIvaroxaban versus NAdroparin in the prevention of venous thromboembolism after total knee arthroplasty surgery: design of a randomised pilot study (DARINA)
por: van Veen, Lucia, et al.
Publicado: (2013)

Rate control drugs differ in the prevention of progression of atrial fibrillation
por: Koldenhof, Tim, et al.
Publicado: (2021)

Bleeding complications of thromboprophylaxis with dabigatran, nadroparin or rivaroxaban for 6 weeks after total knee arthroplasty surgery: a randomised pilot study
por: van der Veen, Lucia, et al.
Publicado: (2021)

Acenocoumarol’s pharmacokinetic: linear or not?
por: Kumar, Parveen, et al.
Publicado: (2019)

Rate control with calcium channel blockers versus betablockers in patients with paroxysmal and persistent atrial fibrillation - data from the AFFIRM trial
por: Koldenhof, T, et al.
Publicado: (2023)

Incidence and outcome of atrial fibrillation: diversity throughout Europe
por: Rienstra, Michiel, et al.
Publicado: (2021)

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation
por: Tieleman, R.G., et al.
Publicado: (2014)

Initial experience with pulsed field ablation for atrial fibrillation
por: Magni, Federico T., et al.
Publicado: (2022)

Newly discovered atrial fibrillation: who(se) care(s)?
por: Crijns, Harry J G M, et al.
Publicado: (2020)

Atrial fibrillation and heart failure temporality: does it matter?
por: Van Deutekom, Colinda, et al.
Publicado: (2022)

Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol
por: Colet, Josep Comín, et al.
Publicado: (2023)

Acenocoumarol: Lack of efficacy: case report
Publicado: (2022)

Cost of dabigatran for atrial fibrillation
por: Gage, Brian F
Publicado: (2011)

Toxidermie médicamenteuse secondaire à l'acénocoumarol
por: Khammassi, Naziha, et al.
Publicado: (2015)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

Update on management of atrial fibrillation in heart failure: a focus on ablation
por: Mulder, Bart A, et al.
Publicado: (2022)

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation
por: Nguyen, Bao-Oanh, et al.
Publicado: (2023)

Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures
por: Mulder, Bart A, et al.
Publicado: (2021)

Anticoagulation Control with Acenocoumarol or Warfarin in Non-Valvular Atrial Fibrillation in Primary Care (Fantas-TIC Study)
por: Dalmau Llorca, M. Rosa, et al.
Publicado: (2021)

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome()
por: Marcos, Ernaldo G., et al.
Publicado: (2019)

Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study
por: Ekrami, Neda Khalilian, et al.
Publicado: (2022)

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study
por: van de Lande, Martijn E, et al.
Publicado: (2023)

Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation
por: Huber, K, et al.
Publicado: (2013)

Spontaneous spinal epidural hematoma in a patient on acenocoumarol for valvular atrial fibrillation: A rare case report
por: El-azrak, Mohammed, et al.
Publicado: (2021)

Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain
por: Rubio-Terrés, Carlos, et al.
Publicado: (2016)

Heart rate increase and inappropriate sinus tachycardia after cryoballoon pulmonary vein isolation for atrial fibrillation
por: van Deutekom, C., et al.
Publicado: (2021)

Telomere length and incident atrial fibrillation – data of the PREVEND cohort
por: Siland, Joylene E., et al.
Publicado: (2017)

Novel Associations of VKORC1 Variants with Higher Acenocoumarol Requirements
por: Anton, Ana Isabel, et al.
Publicado: (2013)

Protective Effect of Pretreatment with Acenocoumarol in Cerulein-Induced Acute Pancreatitis
por: Warzecha, Zygmunt, et al.
Publicado: (2016)

Unusual localization of bleeding under acenocoumarol: Spinal subdural hematoma
por: Aissa, Ismail, et al.
Publicado: (2019)

Acenocoumarol-Induced Diffuse Alveolar Hemorrhage: A Case Report
por: Pawar, Twinkle, et al.
Publicado: (2023)

Effect of nadroparin on anti-Xa activity during nocturnal hemodialysis
por: Buitenwerf, Edward, et al.
Publicado: (2015)

Dabigatran in patients with atrial fibrillation: perioperative and periinterventional management
por: Weltermann, A., et al.
Publicado: (2012)

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders
por: Gorter, Thomas M., et al.
Publicado: (2023)

The Association Between Long-Term Acenocoumarol Treatment and Vitamin D Deficiency
por: Sawicka-Powierza, Jolanta, et al.
Publicado: (2018)

Unintentional ingestion of a high dose of acenocoumarol in a young child
por: Brands, Martijn R, et al.
Publicado: (2021)

Pulmonary vein anatomy addressed by computed tomography and relation to success of second‐generation cryoballoon ablation in paroxysmal atrial fibrillation
por: Mulder, Bart A., et al.
Publicado: (2019)

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure
por: Brandes, Axel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u0bt0g5jsur8g5ehke4mb85oua